Mutant AP endonuclease in patients with amyotrophic lateral sclerosis

Z L Olkowski1

  • 1Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30335-3801, USA.

Neuroreport
|March 21, 1998
PubMed

Insights

Oxidative DNA damage creates abasic sites. Mutations in the AP endonuclease (APE) gene, crucial for repairing these sites, were found in patients with amyotrophic lateral sclerosis (ALS), suggesting a role in disease.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Oxidative DNA damage is frequent, leading to abasic (AP) sites.
  • Defects in AP site repair can cause genome instability and mutations.
  • Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with unknown causes.

Purpose of the Study:

  • To investigate the role of AP endonuclease (APE) gene mutations in ALS pathogenesis.
  • To determine if defects in AP site repair are linked to ALS.
  • To explore the potential of APE mutations in neuronal degeneration.

Main Methods:

  • Genetic analysis of the APE gene in ALS patients.
  • Identification of missense mutations in the APE gene.
  • Correlation of mutations with disease progression and severity.

Main Results:

  • Missense mutations in the APE gene were identified in 8 out of 11 ALS patients.
  • These mutations were found in the gene encoding AP endonuclease, a key DNA repair enzyme.
  • The identified mutations may impair the repair of abasic sites.

Conclusions:

  • Mutated AP endonuclease is implicated in the pathogenesis of ALS.
  • Impaired abasic site repair due to APE mutations may lead to neuronal mutation accumulation and death.
  • This discovery opens new avenues for understanding and potentially treating ALS.